According to the Global Burden of Disease Study from 2015, the leishmaniases are the third most important vector-borne disease after malaria and dengue, with an estimated 1.4 million all-age disability-adjusted life years (a 3.8% increase between 2005 and 2015).[13]

BMJ Best Practice is an evidence-based point of care tool for healthcare practitioners.

To continue reading and access all of BMJ Best Practice's pages you'll need to log in or start a free trial.

You can access through your institution if your hospital, university, trust or other institution provides access to BMJ Best Practice through either OpenAthens or Shibboleth.

Use of this content is subject to our disclaimer